Edition:
United Kingdom

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (ECILC.IS)

ECILC.IS on Istanbul Stock Exchange

4.23TRY
11 Dec 2017
Change (% chg)

-0.06TL (-1.40%)
Prev Close
4.29TL
Open
4.28TL
Day's High
4.30TL
Day's Low
4.22TL
Volume
5,354,630
Avg. Vol
6,928,088
52-wk High
5.08TL
52-wk Low
2.97TL

Latest Key Developments (Source: Significant Developments)

Eis Eczacibasi Q3 net profit rises to 43.9 million lira
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - EIS ECZACIBASI ILAC ::Q3 NET PROFIT OF 43.9 MILLION LIRA VERSUS 26.6 MILLION LIRA YEAR AGO.Q3 REVENUE OF 139.1 MILLION LIRA VERSUS 106.3 MILLION LIRA YEAR AGO.  Full Article

Eczacibasi-Monrol sells Capintec Inc. for 25.0 million lira
Thursday, 1 Sep 2016 

Eis Eczacibasi Ilac :Unit Eczacibasi-Monrol sells 100 percent of Capintec Inc. to V.O.S.S. Varinak Onkoloji for 25.0 million lira ($8.45 million).  Full Article

Eis Eczacibasi unit Eczacıbası-Monrol in talks for sale of Capintec
Thursday, 25 Aug 2016 

Eis Eczacibasi Ilac Sinai : Says its 49.99 percent owned unit Eczacibasi-Monrol Nükleer Urunler starts talks to sell 100 percent of its US-based wholly owned unit Capintec, Inc. .Capintec, Inc operates in nuclear medicine sector by producing and providing services for energy metering devices.  Full Article

Eis Eczacibasi Ilac Q2 net profit up at 76.0 mln lira
Friday, 19 Aug 2016 

Eis Eczacibasi Ilac : Q2 net profit of 76.0 million lira ($25.96 million)versus 18.3 million lira year ago .Q2 revenue of 363.2 million lira versus 286.5 million lira year ago.  Full Article

Eis Eczacibasi Ilac to increase capital by 25 pct through bonus share issues
Thursday, 23 Jun 2016 

Eis Eczacibasi Ilac : To increase share capital to 685.3 million lira ($238.77 million) from 548.2 million lira through bonus share issues .137.1 million lira capital increase will be met by internal resources.  Full Article

Eis Eczacibasi Ilac buys land for 68.0 million lira in Istanbul
Tuesday, 7 Jun 2016 

Eis Eczacibasi Ilac :Buys land for 68.0 million lira ($23.49 million) in Silivri, Istanbul for investment.  Full Article

Eis Eczacibasi Ilac Q1 net profit rises to 35.7 million lira
Tuesday, 24 May 2016 

Eis Eczacibasi Ilac : Q1 net profit of 35.7 million lira ($12.13 million) versus 32.3 million lira year ago .Q1 revenue of 348.8 million lira versus 303.2 lira year ago.  Full Article

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS unit Eczacıbası Baxter to divest several businesses and assets
Monday, 25 Jan 2016 

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS:Unit Eczacıbaşı Baxter decides to end up distribution business of biotechnology products, to sell biotechnology products related assets to Eczacıbası Baxalta Saglık Urunleri (EBAXA) and signs a distribution agreement with EBAXA for distribution of biotechnology products‍​.Unit Eczacibasi Baxter decides to end up distribution business of hospital products, to sell hospital business products related assets to EIP Eczacıbası Ilac Pazarlama and signs a distribution agreement with Baxter Group for distribution of hospital products.Unit Eczacibasi Baxter decides to end up production and distribution business of dialysis and peritoneal dialysis products and sell related assets to Baxter Turkey Renal Hizmetler (Baxter Renal) together with its 60 pct stake in RTS Renal Tedavi Hizmetleri (RTS).  Full Article

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS unit Eczacibasi Baxter to terminate production in Ayazaga facility
Friday, 22 Jan 2016 

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS:Unit Eczacibasi Baxter Hastane Urunleri decides to terminate production in Ayazaga, Istanbul facility until Dec. 31 gradually due to urban transformation project in Ayazaga and Baxter's group's worldwide reorganization plans.Within this framework employees' contracts in the aforementioned facility will be terminated until end of 2016 after payment of all rights and obligations.  Full Article